Isesaki, Japan

Haruo Machida

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruo Machida. Retrieved from https://idiyas.com/inventor/haruo-machida-el1ammki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruo Machida: Innovator in Anti-Viral Research

Introduction

Haruo Machida is a notable inventor based in Isesaki, Japan. He has made significant contributions to the field of anti-viral research through his innovative work on oxetanocin derivatives. His research has the potential to impact the development of effective anti-viral therapies.

Latest Patents

Haruo Machida holds a patent for "Oxetanocin derivatives and their salts as well as use thereof." This patent describes oxetanocin derivatives represented by a specific formula, wherein X can represent H or a pharmacologically acceptable salt. These compounds exhibit anti-viral activity, and the patent also covers anti-viral compositions that include these derivatives as effective ingredients.

Career Highlights

Machida is associated with Nippon Kayaku Co., Ltd., a company known for its commitment to pharmaceutical innovation. His work has contributed to the advancement of anti-viral treatments, showcasing his expertise in medicinal chemistry.

Collaborations

Some of his notable coworkers include Katsuhiko Kurabayashi and Junichi Seki. Their collaborative efforts have furthered research in the field and enhanced the development of new therapeutic solutions.

Conclusion

Haruo Machida's contributions to anti-viral research through his patented innovations highlight his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…